Myasthenia Gravis Educational Series
8 episodes - English - Latest episode: about 12 years ago - ★★★★ - 14 ratingsDr. Ted Burns from the University of Virginia and a member of the M/SAB is producing a series of patient oriented podcasts for MGFA with information on the diagnosis, treatment, and management of MG. Watch here for future podcasts. As always, consult with your physician directly before making any medical decisions.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Medications used in Myasthenia Gravis: The Patient Perspective
May 02, 2012 16:08 - 16 MBA brief overview of myasthenia gravis, part II: Review of the cause of MG, brief overview of treatments and a discussion about vaccines and MG
April 02, 2012 04:53 - 22.4 MBDr. Ted Burns from the University of Virginia talks with Dr. Don Sanders from Duke University and with Dr. Bob Pascuzzi from Indiana University. The participants review the cause of MG (autoimmune), briefly introduce the topic of treatment (which will be discussed in more detail in another MGFA podcast) and talk about the safety of vaccines for patients with MG.
Living Healthy and Active Lives: The Patient Perspective
April 02, 2012 04:53 - 9.5 MBTop 5 lists of what a patient needs to know about living with MG
April 02, 2012 04:53 - 27.4 MBA brief overview of myasthenia gravis, part I: clinical manifestations and diagnosis of MG
April 02, 2012 04:53 - 28 MBDr. Ted Burns from the University of Virginia talks with Dr. Don Sanders from Duke University and with Dr. Bob Pascuzzi from Indiana University. They discuss the common presenting symptoms of MG, what symptoms should be of most concern to the patient and family, how the diagnosis is made and that natural history of MG.
What the patient and caregiver should know about prescription drugs and MG
April 02, 2012 04:53 - 24.9 MBDr. Ted Burns from the University of Virginia talks with Dr. Gil Wolfe from the University of Texas Southwestern and with Dr. James Howard from the University of North Carolina. The participants discuss the use and management of drugs used for other conditions in the context of a diagnosis of MG. They discuss which drugs are best to avoid, if possible, and offer advice on how patients and families can work with clinicians to navigate through the list of potentially dangerous drugs.